Sports or statins for atheroprotection? New insight from Kruppel-like factor 2.
Thum
Thomas
T
Bauersachs
Johann
J
D050197:Atherosclerosis / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D002320:Cardiovascular Physiological Phenomena; D004730:Endothelium, Vascular / Q000378:metabolism / Q000503:physiopathology; D015444:Exercise / Q000502:physiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D051741:Kruppel-Like Transcription Factors / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D012039:Regional Blood Flow; D013177:Sports; D014664:Vasodilation
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; C096161:KLF2 protein, human; D051741:Kruppel-Like Transcription Factors; D009569:Nitric Oxide; D052250:Nitric Oxide Synthase Type III